COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Independent opinion of independent director of Jilin Zixin Pharmaceutical Co., Ltd. on the permanent replenishment of working ca
Independent Director of Jilin Zixin Pharmaceutical Co., Ltd.
Independent opinion on the permanent replenishment of working capital for individual fund-raising funds
According to the "Shenzhen Stock Exchange Listing Rules", "Shenzhen Stock Exchange SME Board Listed Companies Standard Operation Guidelines" and other laws and regulations and the "Articles of Association", "the company's fund-raising special storage system" and other relevant provisions, as Jilin Zixin The independent directors of Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”) have carefully considered the “Proposal on Permanently Replenishing Working Capital for Individually Raised Funds” at the 10th meeting of the 5th Board of Directors, and issued independent opinions as follows:
The company's single fund-raising funds will permanently supplement the company's working capital, which can effectively promote the company's development and reduce the company's financial expenses. The surplus fund raised by the Yanji plant will not have any impact on other fund-raising projects, which is in line with the company's development needs. And the principle of maximizing the interests of shareholders. The company's single fund-raising funds for permanent replenishment of working capital are in line with the “Guidelines for the Standardized Operation of SME Board Listed Companies of Shenzhen Stock Exchange”, “Memorandum of Information Disclosure of SME Board No. 29: Use of Raised Funds” and the “Management System of Raised Funds” 》 and other relevant regulations. The company has not conducted venture capital investment in the past 12 months. At the same time, the company promises not to invest in high-risk investments such as securities investment and provide financial assistance to others within 12 months after the permanent replenishment of working capital. Therefore, the company agreed to the company's ginseng product serialization project (Yanji Plant) surplus fundraising account balance of about 25,374,400 yuan (including interest income) to permanently replenish liquidity, and agreed to submit the proposal to the company's first temporary shareholders in 2014 The meeting deliberated.
Fu Wei Li Fei Wang Xu
January 9, 2014